These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3838134)

  • 1. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
    Goss PE; Jarman M; Griggs LJ
    Br J Cancer; 1985 Feb; 51(2):259-62. PubMed ID: 3838134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metabolite.
    Jarman M; Foster AB; Goss PE; Griggs LJ; Howe I; Coombes RC
    Biomed Mass Spectrom; 1983 Nov; 10(11):620-5. PubMed ID: 6689274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved method for the quantification of aminoglutethimide in urine samples.
    van Tellingen O; Bonfrer JM; Nooyen WJ; Bruning PF
    Clin Chim Acta; 1987 Oct; 169(1):99-108. PubMed ID: 3677440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic separation and measurement of optical isomers of aminoglutethimide and its acetyl metabolite in plasma, saliva, and urine.
    Alshowaier IA; el-Yazigi A; Ezzat A; el-Warith AA; Nicholls PJ
    Ther Drug Monit; 1995 Oct; 17(5):538-43. PubMed ID: 8585120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites.
    Foster AB; Griggs LJ; Howe I; Jarman M; Leung CS; Manson D; Rowlands MG
    Drug Metab Dispos; 1984; 12(4):511-6. PubMed ID: 6148221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of metabolites of 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione, a potential breast cancer drug.
    Poon GK; McCague R; Griggs LJ; Jarman M; Lewis IA
    J Chromatogr; 1991 Dec; 572(1-2):143-57. PubMed ID: 1818050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct enantiomeric high performance liquid chromatographic separation of aminoglutethimide and its major metabolite on a series of Chiralcel OD and Chiralcel OJ columns and its application to biological fluids.
    Aboul-Enein HY; Islam MR
    Biomed Chromatogr; 1991 Mar; 5(2):74-7. PubMed ID: 1868261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients.
    Alshowaier IA; el-Yazigi A; Ezzat A; Abd el-Warith A; Nicholls PJ
    J Clin Pharmacol; 1999 Nov; 39(11):1136-42. PubMed ID: 10579143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokinetics.
    Seago A; Goss PE; Griggs LJ; Jarman M
    Biochem Pharmacol; 1986 Sep; 35(17):2911-6. PubMed ID: 3741481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer.
    Miller AA; Miller BE; Höffken K; Schmidt CG
    Cancer Chemother Pharmacol; 1987; 20(4):337-41. PubMed ID: 3690808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses.
    Strocchi E; Camaggi CM; Martoni A; Cellerino R; Miseria S; Malacarne P; Indelli M; Balli M; Bonciarelli G; Ambroso G
    Cancer Chemother Pharmacol; 1991; 27(6):451-5. PubMed ID: 2013115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.
    Stuart-Harris R; Bradbrook I; Morrison P; Smith IE; Rogers HJ
    Br J Cancer; 1985 Apr; 51(4):485-92. PubMed ID: 3978028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphically acetylated aminoglutethimide in humans.
    Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
    Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of aminoglutethimide and N-acetylaminoglutethimide in human plasma by reversed-phase liquid chromatography.
    Schanche JS; Lønning PE; Ueland PM; Kvinnsland S
    Ther Drug Monit; 1984; 6(2):221-6. PubMed ID: 6740741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer.
    Lønning E; Kvinnsland S; Bakke OM
    Clin Pharmacol Ther; 1984 Dec; 36(6):796-802. PubMed ID: 6499359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglutethimide therapy in breast cancer: relationship of blood levels to drug-related side effects.
    Demers LM; Boucher AE; Santen RJ
    Clin Physiol Biochem; 1987; 5(5):287-91. PubMed ID: 3652603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay for simultaneous estimation of aminoglutethimide and acetylaminoglutethimide in biological fluids.
    Adam AM; Bradbrook ID; Rogers HJ
    Cancer Chemother Pharmacol; 1985; 15(2):176-8. PubMed ID: 4017167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
    MacNeill FA; Jones AL; Jacobs S; Lønning PE; Powles TJ; Dowsett M
    Br J Cancer; 1992 Oct; 66(4):692-7. PubMed ID: 1419608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aminoglutethimide - a new drug for the after care in breast cancer].
    Rabe T; Rabe D; Runnebaum B
    Fortschr Med; 1981 Nov; 99(43):1816-8. PubMed ID: 7308944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay for aminoglutethimide and its acetylated metabolite in urine.
    Kamblawi MO; Stevens RG; Nicholls PJ
    J Chromatogr; 1984 Aug; 309(2):431-5. PubMed ID: 6480795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.